Home › NDC Lookup › RxCUI directory › RxCUI 197902

Lorazepam 2 MG Oral Tablet — RxCUI 197902

RxNorm drug concept · Semantic clinical drug
RxCUI 197902 Semantic clinical drug · SCD ● Current RxNorm concept 60 FDA products 204 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197902
Official nameLorazepam 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped60
Package NDCs mapped204
Reported Medicaid activity (SDUD)1,997,968 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lorazepam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the form. Tablets and the oral liquid are for anxiety disorders or short-term anxiety relief. The injection is used in the hospital for status epilepticus and for sed...
  • Take it exactly as your prescriber directs. If you use the liquid concentrate, mix it into water, juice, applesauce or pudding with the supplied dropper, then use it all right away...
  • No, avoid alcohol. Opioids with lorazepam can cause extreme sleepiness, slowed breathing, coma and death. Tell me about every medicine you take so we can check for problems.
  • Can I drink alcohol or take opioids with it?
📖 Read our full Lorazepam guide →

🕸️ Concept Web — How Lorazepam 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lorazepam 2 MG Oral Tablet RxCUI 197902

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lorazepam 6470
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ativan 202479
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lorazepam Oral Tablet 372647
    • Lorazepam Oral Product 1165340
    • Lorazepam Pill 1165341
    • Lorazepam Oral Tablet [Ativan] 91879
    • Ativan Oral Product 1172874
    • Ativan Pill 1172875
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lorazepam 2 MG SCDC · 316170
  • Lorazepam Oral Tablet SCDF · 372647
  • Lorazepam Oral Product SCDG · 1165340
  • Lorazepam Pill SCDG · 1165341

Brand-Name Concepts

  • Lorazepam 2 MG Oral Tablet [Ativan] SBD · 206828
  • Lorazepam 2 MG [Ativan] SBDC · 567636
  • Lorazepam Oral Tablet [Ativan] SBDF · 91879
  • Ativan Oral Product SBDG · 1172874
  • Ativan Pill SBDG · 1172875
  • Ativan BN · 202479

📦 FDA Products & Package NDCs

60 products · 204 package NDCs
204 package NDCs map to RxCUI 197902 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3425-01 100 TABLET in 1 BOTTLE, PLASTIC (0093-3425-01) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-12-28
00093-3425-05 500 TABLET in 1 BOTTLE, PLASTIC (0093-3425-05) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-11-05
00093-3425-10 1000 TABLET in 1 BOTTLE, PLASTIC (0093-3425-10) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-10-11
00093-3426-01 100 TABLET in 1 BOTTLE, PLASTIC (0093-3426-01) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-12-09
00093-3426-05 500 TABLET in 1 BOTTLE, PLASTIC (0093-3426-05) Lorazepam Teva Pharmaceuticals USA, Inc. 2022-01-11
00093-3426-10 1000 TABLET in 1 BOTTLE, PLASTIC (0093-3426-10) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-12-28
00093-3427-01 100 TABLET in 1 BOTTLE, PLASTIC (0093-3427-01) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-07-20
00093-3427-05 500 TABLET in 1 BOTTLE, PLASTIC (0093-3427-05) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-07-20
00093-3427-10 1000 TABLET in 1 BOTTLE, PLASTIC (0093-3427-10) Lorazepam Teva Pharmaceuticals USA, Inc. 2021-07-20
00187-0063-01 100 TABLET in 1 BOTTLE (0187-0063-01) Ativan Bausch Health US LLC 2013-05-01
00187-0064-01 100 TABLET in 1 BOTTLE (0187-0064-01) Ativan Bausch Health US LLC 2013-05-01
00187-0065-01 100 TABLET in 1 BOTTLE (0187-0065-01) Ativan Bausch Health US LLC 2013-05-01
00904-6007-61 100 BLISTER PACK in 1 CARTON (0904-6007-61) / 1 TABLET in 1... Lorazepam Major Pharmaceuticals 2009-10-09
00904-6008-60 100 TABLET in 1 BOTTLE (0904-6008-60) Lorazepam Major Pharmaceuticals 2009-10-09
00904-6008-61 100 BLISTER PACK in 1 CARTON (0904-6008-61) / 1 TABLET in 1... Lorazepam Major Pharmaceuticals 2009-10-09
13107-0083-01 100 TABLET in 1 BOTTLE (13107-083-01) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0083-05 500 TABLET in 1 BOTTLE (13107-083-05) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0083-10 10 TABLET in 1 BOTTLE (13107-083-10) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0083-99 1000 TABLET in 1 BOTTLE (13107-083-99) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0084-01 100 TABLET in 1 BOTTLE (13107-084-01) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0084-05 500 TABLET in 1 BOTTLE (13107-084-05) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0084-10 10 TABLET in 1 BOTTLE (13107-084-10) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0084-99 1000 TABLET in 1 BOTTLE (13107-084-99) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0085-01 100 TABLET in 1 BOTTLE (13107-085-01) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0085-05 500 TABLET in 1 BOTTLE (13107-085-05) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0085-10 10 TABLET in 1 BOTTLE (13107-085-10) LORAZEPAM Aurolife Pharma LLC 2021-02-01
13107-0085-99 1000 TABLET in 1 BOTTLE (13107-085-99) LORAZEPAM Aurolife Pharma LLC 2021-02-01
43353-0255-15 15 TABLET in 1 BOTTLE (43353-255-15) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-30 30 TABLET in 1 BOTTLE (43353-255-30) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-45 45 TABLET in 1 BOTTLE (43353-255-45) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-53 60 TABLET in 1 BOTTLE (43353-255-53) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-60 90 TABLET in 1 BOTTLE (43353-255-60) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-70 120 TABLET in 1 BOTTLE (43353-255-70) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-75 150 TABLET in 1 BOTTLE (43353-255-75) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-80 180 TABLET in 1 BOTTLE (43353-255-80) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-90 240 TABLET in 1 BOTTLE (43353-255-90) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
43353-0255-92 270 TABLET in 1 BOTTLE (43353-255-92) Lorazepam Aphena Pharma Solutions - Tennessee, LLC 2018-10-22
51407-0996-01 100 TABLET in 1 BOTTLE, PLASTIC (51407-996-01) Lorazepam Golden State Medical Supply, Inc. 2025-03-17
51407-0997-01 100 TABLET in 1 BOTTLE, PLASTIC (51407-997-01) Lorazepam Golden State Medical Supply, Inc. 2025-03-17
51407-0998-01 100 TABLET in 1 BOTTLE, PLASTIC (51407-998-01) Lorazepam Golden State Medical Supply, Inc. 2025-03-17
58118-0904-08 30 TABLET in 1 BLISTER PACK (58118-0904-8) Lorazepam Clinical Solutions Wholesale, LLC 2019-02-15
58118-1095-08 30 TABLET in 1 BLISTER PACK (58118-1095-8) Lorazepam Clinical Solutions Wholesale, LLC 2019-02-15
58118-1096-08 30 TABLET in 1 BLISTER PACK (58118-1096-8) Lorazepam Clinical Solutions Wholesale, LLC 2019-02-15
60687-0820-01 100 BLISTER PACK in 1 CARTON (60687-820-01) / 1 TABLET in 1... Lorazepam American Health Packaging 2025-09-14
60687-0831-01 100 BLISTER PACK in 1 CARTON (60687-831-01) / 1 TABLET in 1... Lorazepam American Health Packaging 2025-09-14
60687-0842-01 100 BLISTER PACK in 1 CARTON (60687-842-01) / 1 TABLET in 1... Lorazepam American Health Packaging 2025-09-14
62135-0861-01 100 TABLET in 1 BOTTLE (62135-861-01) Lorazepam Chartwell RX, LLC 2024-11-06
62135-0862-01 100 TABLET in 1 BOTTLE (62135-862-01) Lorazepam Chartwell RX, LLC 2024-11-06
62135-0863-01 100 TABLET in 1 BOTTLE (62135-863-01) Lorazepam Chartwell RX, LLC 2024-11-06
62559-0195-01 100 TABLET in 1 BOTTLE (62559-195-01) Lorazepam ANI Pharmaceuticals, Inc. 2024-12-01
Observed labelers: Aphena Pharma Solutions - Tennessee, LLC (62) · Asclemed USA, Inc. (18) · Bryant Ranch Prepack (16) · PD-Rx Pharmaceuticals, Inc. (16) · Aurolife Pharma LLC (12) · SUN PHARMACEUTICAL INDUSTRIES INC (12) · +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.